background image

Clinical Trials In Mississippi

Discover hundreds of clinical trials in Mississippi.
Search clinical trials in Mississippi by city, condition or phase.

e.g. Respiratory Diseases
MississippiHealthy volunteers: No

A Study to Evaluate Efficacy and Safety of Intravenous ACU193 in Participants With Early Alzheimer's Disease (ALTITUDE-AD)

Recruiting
Phase 2
Phase 3

Sponsor:

Acumen Pharmaceuticals

Location:

Hattiesburg, Carlsbad, Fullerton, Irvineshow 45 more

Code:

NCT06335173

Conditions

Alzheimer Disease

Eligibility Criteria

Sex: All

Age: 50 - 70+

Healthy Volunteers: Not accepted

Interventions

ACU193

Placebo

A Study Evaluating the Safety and Efficacy of EDIT-301 in Participants With Severe Sickle Cell Disease (RUBY)

Recruiting
Phase 1
Phase 2

Sponsor:

Editas Medicine, Inc.

Location:

Jackson, Oakland, Aurora, New Havenshow 14 more

Code:

NCT04853576

Conditions

Sickle Cell Disease

Hemoglobinopathies

Eligibility Criteria

Sex: All

Age: 12 - 50

Healthy Volunteers: Not accepted

Interventions

EDIT-301

A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)

Recruiting
Phase 3

Sponsor:

Melt Pharmaceuticals

Location:

Bay Saint Louis, Chico, Grand Junction, Jacksonvilleshow 8 more

Code:

NCT06383273

Conditions

Cataract

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

MELT-300 sublingual tablet

Midalozam sublingual tablet

Placebo sublingual tablet

Do AxoGuard Implants Decrease Shoulder Disability After Neck Dissections

Recruiting

Sponsor:

University of Mississippi Medical Center

Location:

Jackson

Code:

NCT03941327

Conditions

Spinal Accessory Nerve Injury

Cervical Lymphadenopathy

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

AxoGuard Nerve Cuff

Study of PK and Safety of the LicartTM Topical System in Pediatric and Adult Participants With Minor Soft Tissue Injury

Recruiting
Phase 3

Sponsor:

IBSA Institut Biochimique SA

Location:

Vicksburg, Raymond, Little Rock, La Palmashow 12 more

Code:

NCT05171673

Conditions

Soft Tissue Injuries

Eligibility Criteria

Sex: All

Age: 6 - 45

Healthy Volunteers: Not accepted

Interventions

Licart™ (diclofenac epolamine) topical system

Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis

Recruiting
Phase 2

Sponsor:

Kowa Research Institute, Inc.

Location:

Jackson, Flowood, Homewood, Conwayshow 29 more

Code:

NCT05327127

Conditions

NASH

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

K-877-ER

CSG452

Placebo

Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis

Recruiting
Phase 3

Sponsor:

AbbVie

Location:

Hattiesburg, Flagstaff, Glendale, Peoriashow 69 more

Code:

NCT05814627

Conditions

Rheumatoid Arthritis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Upadacitinib

Adalimumab

Upadacitinib Matching Placebo

Adalimumab Matching Placebo

MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study

Recruiting

Sponsor:

Vertos Medical, Inc.

Location:

Tupelo, Starkville, Pascagoula, Meridianshow 932 more

Code:

NCT03072927

Conditions

Lumbar Spinal Stenosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

MILD

SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors

Recruiting

Sponsor:

American Thrombosis and Hemostasis Network

Location:

Madison, Phoenix, Little Rock, Los Angelesshow 20 more

Code:

NCT04647227

Conditions

Hemophilia A With Inhibitor

Hemophilia B With Inhibitor

Eligibility Criteria

Sex: All

Age: 12 - 70+

Healthy Volunteers: Not accepted

Interventions

coagulation factor VIIa [recombinant]-jncw

Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults

Recruiting
Phase 3

Sponsor:

National Cancer Institute (NCI)

Location:

Southhaven, Birmingham, Anchorage, Fort Smithshow 135 more

Code:

NCT04530565

Conditions

B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Blinatumomab

Bone Marrow Aspiration and Biopsy

Cyclophosphamide

Cytarabine